Warren Hosseinion Acquires 252 Shares of Nutex Health (NASDAQ:NUTX) Stock

Nutex Health Inc. (NASDAQ:NUTX) President Warren Hosseinion bought 252 shares of the company’s stock in a transaction that occurred on Thursday, March 19th. The stock was purchased at an average price of $94.07 per share, for a total transaction of $23,705.64. Following the acquisition, the president owned 7,765 shares of the company’s stock, valued at $730,453.55. This trade represents a 3.35% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Nutex Health Stock Performance

Shares of Nutex Health stock opened at $99.49 on Wednesday. The business has a 50-day moving average price of $117.38 and a two-hundred day moving average price of $125.46. Nutex Health Inc. has a 1-year low of $45.88 and a 1-year high of $193.07. The company has a current ratio of 3.41, a quick ratio of 3.39 and a debt-to-equity ratio of 0.70. The company has a market cap of $693.45 million, a P/E ratio of 11.08 and a beta of 0.03.

Nutex Health (NASDAQ:NUTX) last announced its quarterly earnings data on Thursday, March 5th. The company reported $1.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.56 by ($3.95). Nutex Health had a net margin of 7.34% and a return on equity of 17.67%. The business had revenue of $151.68 million during the quarter, compared to analyst estimates of $258.82 million.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on NUTX shares. Weiss Ratings restated a “hold (c)” rating on shares of Nutex Health in a report on Monday, December 29th. Wall Street Zen downgraded shares of Nutex Health from a “strong-buy” rating to a “hold” rating in a research report on Saturday, March 7th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, Nutex Health presently has an average rating of “Moderate Buy” and a consensus target price of $252.50.

Nutex Health News Summary

Here are the key news stories impacting Nutex Health this week:

• Positive Sentiment: Company insiders bought stock — President Warren Hosseinion purchased 252 shares (~$94.07 avg) and Director Frank Jaumot purchased 150 shares (~$93.56 avg); small dollar amounts but a direct vote of confidence from management. Warren Hosseinion Purchase Frank Jaumot Purchase
• Neutral Sentiment: Multiple short?interest reports for March show “0” shares and a days?to?cover of 0.0 — this either indicates extremely low short interest (limited short pressure) or data/reporting errors; it reduces the likelihood of near?term short squeezes but may not be actionable without confirmation.
• Neutral Sentiment: Institutional ownership has been active historically (new stakes from several managers), but current institutional ownership remains relatively modest; this can support liquidity but isn’t a clear catalyst in the near term.
• Negative Sentiment: Recent quarterly results (reported March 5) showed an EPS miss ($1.61 vs. $5.56 est.) and revenue shortfall ($151.7M vs. $258.8M est.), which remains a material negative for valuation and could limit upside until growth/revenue trends improve.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Islay Capital Management LLC acquired a new stake in shares of Nutex Health in the 4th quarter worth about $34,000. State of Alaska Department of Revenue purchased a new stake in shares of Nutex Health in the third quarter worth approximately $30,000. BNP Paribas Financial Markets raised its stake in shares of Nutex Health by 966.7% in the second quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock worth $40,000 after purchasing an additional 290 shares during the last quarter. Ameritas Investment Partners Inc. bought a new position in shares of Nutex Health in the second quarter valued at approximately $44,000. Finally, Royal Bank of Canada lifted its holdings in shares of Nutex Health by 752.4% in the fourth quarter. Royal Bank of Canada now owns 358 shares of the company’s stock valued at $59,000 after purchasing an additional 316 shares in the last quarter. 5.32% of the stock is currently owned by institutional investors and hedge funds.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight?loss services and behavioral health support. By combining in?person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost?effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail?anchored centers, offering treatment for non?life?threatening injuries and illnesses, preventive screenings and basic primary care.